Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
37.65
-2.75 (-6.81%)
At close: Jan 28, 2026, 4:00 PM EST
37.87
+0.22 (0.58%)
Pre-market: Jan 29, 2026, 7:00 AM EST
Hinge Health Stock Forecast
Stock Price Forecast
The 16 analysts that cover Hinge Health stock have a consensus rating of "Strong Buy" and an average price target of $60.13, which forecasts a 59.71% increase in the stock price over the next year. The lowest target is $45 and the highest is $70.
Price Target: $60.13 (+59.71%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Hinge Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Buy | 9 | 9 | 9 | 9 | 9 | 10 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 15 | 15 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Freedom Capital Markets | Freedom Capital Markets | Strong Buy Initiates $59 | Strong Buy | Initiates | $59 | +56.71% | Jan 23, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $71 → $60 | Buy | Maintains | $71 → $60 | +59.36% | Jan 9, 2026 |
| Wells Fargo | Wells Fargo | Buy Initiates $68 | Buy | Initiates | $68 | +80.61% | Jan 9, 2026 |
| Keybanc | Keybanc | Buy Maintains $72 → $70 | Buy | Maintains | $72 → $70 | +85.92% | Jan 8, 2026 |
| Needham | Needham | Strong Buy Reiterates $59 | Strong Buy | Reiterates | $59 | +56.71% | Jan 6, 2026 |
Financial Forecast
Revenue This Year
585.21M
from 390.40M
Increased by 49.90%
Revenue Next Year
715.12M
from 585.21M
Increased by 22.20%
EPS This Year
1.48
from -0.88
EPS Next Year
1.56
from 1.48
Increased by 5.31%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 609.1M | 776.9M | ||||
| Avg | 585.2M | 715.1M | ||||
| Low | 560.7M | 659.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 56.0% | 32.8% | ||||
| Avg | 49.9% | 22.2% | ||||
| Low | 43.6% | 12.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.38 | 2.04 | ||||
| Avg | 1.48 | 1.56 | ||||
| Low | 1.20 | 0.71 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 37.7% | ||||
| Avg | - | 5.3% | ||||
| Low | - | -52.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.